Abstract
Subcutaneous implantation of DBA/2-derived L5178Y cells into DBA/2 mice followed 10 d later by nodule excision protected 100% of mice from the rapid outgrowth of an intraperitoneal challenge of L5178Y cells given 7 d postexcision. Challenged mice remained clinically normal for 48--250 d before onset of an ultimately fatal tumor outgrowth. The numbers of L5178Y cells in the peritoneal cavity increased logarithmically for 4 d after challenge and then declined to low but detectable levels which persisted throughout the clinically normal period. Cells active in 18-h in vitro cytolytic assays against 51Cr-labeled L5178Y target cells were found in the peritoneal cavity. The effector cells were determined to be Thy1.2 positive. Their activity was tumor specific and reached peak levels 4 d after tumor challenge and then gradually declined to undectable levels during the following 70 d. Tumor emergence occurred most frequently during the period when CMC activity was no longer demonstrable in the remaining clinically normal mice. A transient peak of low level cytophilic antitumor antibody was detected about 30 d after tumor cell challenge. The temporal associations between the numbers of tumor cells and the levels of cell-mediated lysis against L5178Y cells indicate the importance of the cell-mediated cytolysis response in limiting initial tumor outgrowth and suggest its role as one of the factors responsible for long-term tumor suppression during tumor dormancy.
Full Text
The Full Text of this article is available as a PDF (821.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Benjamini E., Fong S., Erickson C., Leung C. Y., Rennick D., Scibienski R. J. Immunity to lymphoid tumors in syngeneic mice by immunization with mitomycin C-treated cells. J Immunol. 1977 Feb;118(2):685–693. [PubMed] [Google Scholar]
- Cikes M., Friberg S., Jr Expression of H-2 and Moloney leukemia virus-determined cell-surface antigens in synchronized cultures of a mouse cell line. Proc Natl Acad Sci U S A. 1971 Mar;68(3):566–569. doi: 10.1073/pnas.68.3.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clarkson B. D., Fried J., Chou T. C., Strife A., Ferguson R., Sullivan S., Kitahara T., Oyama A. Duration of the dormant state in an established cell line of human hematopoietic cells. Cancer Res. 1977 Dec;37(12):4506–4522. [PubMed] [Google Scholar]
- Clarkson B., Ota K., Ohkita T., O'Connor A. Kinetics of proliferation of cancer cells in neoplastic effusions in man. Cancer. 1965 Oct;18(10):1189–1213. doi: 10.1002/1097-0142(196510)18:10<1189::aid-cncr2820181002>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- DeCosse J. J., Gelfant S. Noncycling tumor cells: mitogenic response to antilymphocytic serum. Science. 1968 Nov 8;162(3854):698–699. doi: 10.1126/science.162.3854.698. [DOI] [PubMed] [Google Scholar]
- DerHagopian R. P., Sugarbaker E. V., Ketcham A. Inflammatory oncotaxis. JAMA. 1978 Jul 28;240(4):374–375. [PubMed] [Google Scholar]
- Dresser D. W., Mitchison N. A. The mechanism of immunological paralysis. Adv Immunol. 1968;8:129–181. doi: 10.1016/s0065-2776(08)60466-6. [DOI] [PubMed] [Google Scholar]
- FISHER B., FISHER E. R. Experimental evidence in support of the dormant tumor cell. Science. 1959 Oct 9;130(3380):918–919. doi: 10.1126/science.130.3380.918. [DOI] [PubMed] [Google Scholar]
- Fenyö E. M., Klein E., Klein G., Swiech K. Selection of an immunoresistant Moloney lymphoma subline with decreased concentration of tumor-specific surface antigens. J Natl Cancer Inst. 1968 Jan;40(1):69–89. [PubMed] [Google Scholar]
- Fialkow P. J., Klein E., Klein G., Clifford P., Singh S. Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma. J Exp Med. 1973 Jul 1;138(1):89–102. doi: 10.1084/jem.138.1.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fridman W. H., Guimezanes A., Gisler R. H. Characterization of suppressive immunoglobulin-binding factor (IBF). I. Production of IBF by a theta-positive lymphoma (L-5178-Y). J Immunol. 1977 Oct;119(4):1266–1268. [PubMed] [Google Scholar]
- Gelfant S. A new concept of tissue and tumor cell proliferation. Cancer Res. 1977 Nov;37(11):3845–3862. [PubMed] [Google Scholar]
- Gimbrone M. A., Jr, Leapman S. B., Cotran R. S., Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med. 1972 Aug 1;136(2):261–276. doi: 10.1084/jem.136.2.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HADFIELD G. The dormant cancer cell. Br Med J. 1954 Sep 11;2(4888):607–610. doi: 10.1136/bmj.2.4888.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harada M., Pearson G., Redmon L., Winters E., Kasuga S. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system. J Immunol. 1975 Apr;114(4):1318–1322. [PubMed] [Google Scholar]
- Herberman R. B., Campbell D. A., Jr, Oldham R. K., Bonnard G. D., Ting C. C., Holden H. T., Glaser M., Djeu J., Oehler R. Immunogenicity of tumor antigens. Ann N Y Acad Sci. 1976;276:26–44. doi: 10.1111/j.1749-6632.1976.tb41634.x. [DOI] [PubMed] [Google Scholar]
- Krahenbuhl J. L., Lambert L. H., Jr, Remington J. S. The effects of activated macrophages on tumor target cells: escape from cytostasis. Cell Immunol. 1976 Aug;25(2):279–293. doi: 10.1016/0008-8749(76)90118-0. [DOI] [PubMed] [Google Scholar]
- Lefford M. J., McGregor D. D. Immunological memory in tuberculosis. I. Influence of persisting viable organisms. Cell Immunol. 1974 Dec;14(3):417–428. doi: 10.1016/0008-8749(74)90192-0. [DOI] [PubMed] [Google Scholar]
- Lerner R. A., Oldstone M. B., Cooper N. R. Cell cycle-dependent immune lysis of Moloney virus-transformed lymphocytes: presence of viral antigen, accessibility to antibody, and complement activation. Proc Natl Acad Sci U S A. 1971 Oct;68(10):2584–2588. doi: 10.1073/pnas.68.10.2584. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MENDELSOHN M. L. Chronic infusion of tritiated thymidine into mice with tumors. Science. 1962 Jan 19;135(3499):213–215. doi: 10.1126/science.135.3499.213. [DOI] [PubMed] [Google Scholar]
- Noble R. L., Hoover L. A classification of transplantable tumors in Nb rats controlled by estrogen from dormancy to autonomy. Cancer Res. 1975 Nov;35(11 Pt 1):2935–2941. [PubMed] [Google Scholar]
- North R. J., Kirstein D. P. T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites. J Exp Med. 1977 Feb 1;145(2):275–292. doi: 10.1084/jem.145.2.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parr I. Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour. Br J Cancer. 1972 Jun;26(3):174–182. doi: 10.1038/bjc.1972.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reese A. B., Archila E. A., Jones I. S., Cooper W. C. Necrosis of malignant melanoma of the choroid. Am J Ophthalmol. 1970 Jan;69(1):91–104. doi: 10.1016/0002-9394(70)91860-x. [DOI] [PubMed] [Google Scholar]
- Sanford B. H. An alteration in tumor histocompatibility induced by neuraminidase. Transplantation. 1967 Sep 5;5(5):1273–1279. doi: 10.1097/00007890-196709000-00005. [DOI] [PubMed] [Google Scholar]
- Shipley W. U. Immune cytolysis in relation to the growth cycle of Chinese hamster cells. Cancer Res. 1971 Jul;31(7):925–929. [PubMed] [Google Scholar]
- Sindelar W. F. Regression of cancer following surgery. Natl Cancer Inst Monogr. 1976 Nov;44:81–84. [PubMed] [Google Scholar]
- Sparks F. C., Ting C. C., Hammond W. G., Herberman R. B. An isotopic antiglobulin technique for measuring antibodies to cell-surface antigens. J Immunol. 1969 Apr;102(4):842–847. [PubMed] [Google Scholar]
- Thorn R. M., Palmer J. C., Manson L. A. A simplified 51Cr-release assay for killer cells. J Immunol Methods. 1974 Mar;4(2):301–315. doi: 10.1016/0022-1759(74)90073-8. [DOI] [PubMed] [Google Scholar]
- Ting C. C., Herberman R. B. Serological analysis of immune response to friend virus-induced leukemia. Cancer Res. 1974 Jul;34(7):1676–1683. [PubMed] [Google Scholar]
- Weigle W. O. Immunological unresponsiveness. Adv Immunol. 1973;16:61–122. doi: 10.1016/s0065-2776(08)60296-5. [DOI] [PubMed] [Google Scholar]
- Weinhold K. J., Miller D. A., Wheelock E. F. The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its termination. J Exp Med. 1979 Mar 1;149(3):745–757. doi: 10.1084/jem.149.3.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wheelock E. F., Caroline N. L., Moore R. D. Suppression of established Friend virus leukemia by statolon. I. Demonstration of a latent infection in clinically normal mice. J Virol. 1969 Jul;4(1):1–6. doi: 10.1128/jvi.4.1.1-6.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]